High prevalence of human papillomavirus in esophageal squamous cell carcinoma: A study in paired samples

Diseases of the Esophagus

Volumn 26, Issue 3, 2013, Pages 282-287

  Vaiphei, K ^a   Kochhar, R ^a   Bhardawaj, S ^a   Dutta, U ^a   Singh, K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Esophageal mucosa; Esophageal squamous cell carcinoma; Human papillomavirus; Viral genotype

Indexed keywords

PROTEIN P16; PROTEIN P63;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 55; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SMOKING; TUMOR DIFFERENTIATION;

ADULT; AGED; ALPHAPAPILLOMAVIRUS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PAPILLOMAVIRUS INFECTIONS; SMOKING; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; TUMOR VIRUS INFECTIONS;

EID: 84875810785     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01365.x     Document Type: Article

References (34)

1. Parkin D M, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Parkin D M, Bray F, Ferlay J, Pisani P. Estimates of the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
3. Li M H, Li P, Li P J. Recent progress in research on esophageal cancer in China. Adv Cancer Res 1980; 33: 173-249.
4. ICMR. National Cancer Registry Programme, 1981-2001, an Overview. New Delhi: Indian Council of Medical Research, 2002.
5. Jarrett W F. The Leeuwenhoek lecture, 1986. Environmental carcinogens and papillomaviruses in the pathogenesis of cancer. Proc R Soc Lond B Biol Sci 1987; 231: 1-11.
6. Goff J S. Infectious causes of esophagitis. Annu Rev Med 1988; 39: 163-9.
7. Syrjanen K J. HPV infections oesophageal cancer. J Clin Pathol 2002; 55: 721-8.
8. Munoz N, Bosch F X, de Sanjose S etal., International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 3486: 518-27.
9. Gillison M L, Shah K V. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003; 31: 57-65.
10. World Health Organization. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 90. Human papillomaviruses. WHO Press: Lyon, 2007.
11. Syrjanen K, Pyrhonen S, Aukee S, Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982; 5: 291-6.
12. Bouvard V, Baan R, Straif K etal., on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009; 10: 321-2.
13. Poljak M, Cerar A, Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 1998; 29: 266-71.
14. Khurshid A, Kazuya N, Hanae I, Manabu I. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. J Pak Med Assoc 1998; 48: 138-42.
15. Smits H L, Tjong-A-Hung S P, ter Schegget J, Nooter K, Kok T. Absence of human papillomavirus DNA from esophageal carcinoma as determined by multiple broad spectrum polymerase chain reactions. J Med Virol 1995; 46: 213-5.
16. Westfall M D, Pietenpol J A. p63: molecular complexity in development and cancer. Carcinogenesis 2004; 25: 857-64.
17. Wang T Y, Chen B F, Yang Y C etal. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001; 32: 479-86.
18. Herrera-Goepfert R, Lizano M, Akiba S, Becker-D'Acosta M. Human papilloma virus and esophageal carcinoma in a Latin-American region. World J Gastroenterol 2009; 15: 3142-7.
19. Berumen-Campos J. Human papilloma virus and cervical cancer. Gac Med Mex 2006; 142 (Suppl 2): 51-9.
20. Benamouzig R, Jullian E, Chang F etal. Absence of human papillomavirus DNA detected by polymerase chain reaction in French patients with esophageal carcinoma. Gastroenterol 1995; 109: 1876-81.
21. Bjorge T, Hakulinen T, Engeland A etal. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.
22. Van Doornum G J, Korse C M, Buning-Kager J C etal. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer 2003; 88: 1095-100.
23. Kamangar F, Qiao Y L, Schiller J T etal. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer 2006; 119: 579-84.
24. Lu Y, Zhang Z, Liu Q etal. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model. Biol Pharm Bull 2007; 30: 150-6.
25. Katiyar S, Hedau S, Jain N etal. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005; 218: 69-79.
26. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol 2005; 11: 1200-3.
27. Rodriguez A C, Schiffman M, Herrero R etal. Proyecto Epidemiologico Guanacaste Group. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100: 513-7.
28. Xi L F, Koutsky L A, Castle P E etal. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev 2009; 18: 3490-6.
29. American Cancer Society. Cigarette smoking linked to increased human papillomavirus DNA load. CA Cancer J Clin 2010; 60: 137-8.
30. Shen Z Y, Hu S P, Lu L C etal. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68: 412-6.
31. de Villiers E-M, Fauquet C, Broker T R, Bernard H U, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17-27.
32. Tokunaga T, Sugihara H, Tani T, Hattori T. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002; 62: 4938-44.
33. Dhillon P K, Barry M, Stamper M J etal. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009; 18: 595-600.
34. Au N H, Gown A M, Cheang M etal. p63 expression in lung carcinoma: a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 2004; 12: 240-7.